These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 20150940

  • 1. Does the downregulation of the FGF23 signaling pathway in hyperplastic parathyroid glands contribute to refractory secondary hyperparathyroidism in CKD patients?
    Lafage-Proust MH.
    Kidney Int; 2010 Mar; 77(5):390-2. PubMed ID: 20150940
    [Abstract] [Full Text] [Related]

  • 2. PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop.
    Lavi-Moshayoff V, Wasserman G, Meir T, Silver J, Naveh-Many T.
    Am J Physiol Renal Physiol; 2010 Oct; 299(4):F882-9. PubMed ID: 20685823
    [Abstract] [Full Text] [Related]

  • 3. Klotho, FGF23, and FGF receptors in chronic kidney disease: a yin-yang situation?
    Drüeke TB.
    Kidney Int; 2010 Dec; 78(11):1057-60. PubMed ID: 21076444
    [Abstract] [Full Text] [Related]

  • 4. Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients.
    Krajisnik T, Olauson H, Mirza MA, Hellman P, Akerström G, Westin G, Larsson TE, Björklund P.
    Kidney Int; 2010 Nov; 78(10):1024-32. PubMed ID: 20686451
    [Abstract] [Full Text] [Related]

  • 5. Persistent fibroblast growth factor 23 signalling in the parathyroid glands for secondary hyperparathyroidism in mice with chronic kidney disease.
    Kawakami K, Takeshita A, Furushima K, Miyajima M, Hatamura I, Kuro-O M, Furuta Y, Sakaguchi K.
    Sci Rep; 2017 Jan 17; 7():40534. PubMed ID: 28094278
    [Abstract] [Full Text] [Related]

  • 6. Dual-specificity phosphatases are implicated in severe hyperplasia and lack of response to FGF23 of uremic parathyroid glands from rats.
    Román-García P, Carrillo-López N, Naves-Díaz M, Rodríguez I, Ortiz A, Cannata-Andía JB.
    Endocrinology; 2012 Apr 17; 153(4):1627-37. PubMed ID: 22334717
    [Abstract] [Full Text] [Related]

  • 7. Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients.
    Komaba H, Goto S, Fujii H, Hamada Y, Kobayashi A, Shibuya K, Tominaga Y, Otsuki N, Nibu K, Nakagawa K, Tsugawa N, Okano T, Kitazawa R, Fukagawa M, Kita T.
    Kidney Int; 2010 Feb 17; 77(3):232-8. PubMed ID: 19890272
    [Abstract] [Full Text] [Related]

  • 8. FGF23 fails to inhibit uremic parathyroid glands.
    Canalejo R, Canalejo A, Martinez-Moreno JM, Rodriguez-Ortiz ME, Estepa JC, Mendoza FJ, Munoz-Castaneda JR, Shalhoub V, Almaden Y, Rodriguez M.
    J Am Soc Nephrol; 2010 Jul 17; 21(7):1125-35. PubMed ID: 20431039
    [Abstract] [Full Text] [Related]

  • 9. A correlation between decreased parathyroid α-Klotho and fibroblast growth factor receptor 1 expression with pathological category and parathyroid gland volume in dialysis patients.
    Yan J, Jingbo C, Wang D, Xie S, Yuan L, Zhong X, Hao L.
    Int Urol Nephrol; 2015 Apr 17; 47(4):701-6. PubMed ID: 25749987
    [Abstract] [Full Text] [Related]

  • 10. miR-129 Blocks Secondary Hyperparathyroidism-Inducing Fgf23/αKlotho Signaling in Mice with Chronic Kidney Disease.
    Xu M, Li H, Bai Y, He J, Chen R, An N, Li Y, Dong Y.
    Am J Med Sci; 2021 May 17; 361(5):624-634. PubMed ID: 33781552
    [Abstract] [Full Text] [Related]

  • 11. Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease.
    Galitzer H, Ben-Dov IZ, Silver J, Naveh-Many T.
    Kidney Int; 2010 Feb 17; 77(3):211-8. PubMed ID: 20016468
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. FGF23 and the parathyroid.
    Silver J, Naveh-Many T.
    Adv Exp Med Biol; 2012 Feb 17; 728():92-9. PubMed ID: 22396164
    [Abstract] [Full Text] [Related]

  • 16. Effects of FGF-23-mediated ERK/MAPK signaling pathway on parathyroid hormone secretion of parathyroid cells in rats with secondary hyperparathyroidism.
    Chen XJ, Chen X, Wu WJ, Zhou Q, Gong XH, Shi BM.
    J Cell Physiol; 2018 Sep 17; 233(9):7092-7102. PubMed ID: 29633272
    [Abstract] [Full Text] [Related]

  • 17. Increased parathyroid expression of klotho in uremic rats.
    Hofman-Bang J, Martuseviciene G, Santini MA, Olgaard K, Lewin E.
    Kidney Int; 2010 Dec 17; 78(11):1119-27. PubMed ID: 20631679
    [Abstract] [Full Text] [Related]

  • 18. Regulation of parathyroid function in chronic kidney disease (CKD).
    Fukagawa M, Nakanishi S, Fujii H, Hamada Y, Abe T.
    Clin Exp Nephrol; 2006 Sep 17; 10(3):175-9. PubMed ID: 17009074
    [Abstract] [Full Text] [Related]

  • 19. Parathyroidectomy in patients with chronic kidney disease: Impacts of different techniques on the biochemical and clinical evolution of secondary hyperparathyroidism.
    Albuquerque RFC, Carbonara CEM, Martin RCT, Dos Reis LM, do Nascimento CP, Arap SS, Moysés RMA, Jorgetti V, Montenegro FLM, de Oliveira RB.
    Surgery; 2018 Feb 17; 163(2):381-387. PubMed ID: 29146232
    [Abstract] [Full Text] [Related]

  • 20. Parathyroid hormone-producing cells exist in adipose tissues surrounding the parathyroid glands in hemodialysis patients with secondary hyperparathyroidism.
    Kakuta T, Sawada K, Kanai G, Tatsumi R, Miyakogawa T, Ishida M, Nakazawa R, Fukagawa M.
    Sci Rep; 2020 Feb 24; 10(1):3290. PubMed ID: 32094398
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.